BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 28, 2009
View Archived Issues
Avila Raises $30M, Pulls Down $200M Deal with Novartis Fund
Biotech start-up Avila Therapeutics Inc. not only raised $30 million in a Series B financing, but snagged a deal potentially worth $200 million in up-front and milestones plus royalties with Novartis Option Fund. (BioWorld Today)
Read More
Cerulean Steps Up 'Tempo,' Gets $10M for Nanoparticles
Read More
GSK Deal, Strong Quarter Get Amgen High Wall Street Marks
Read More
Liraglutide's Good-Data Ride: A Higher Bar for Byetta LAR?
Read More
More Action in the Tools Space: Agilent Buying Varian for $1.5B
Read More
Other News To Note
Read More
Clinic Roundup
Read More